Group 3A: HER2+ Breast Cancer; Biomarkers

Name: Group 3A: HER2+ Breast Cancer; Biomarkers
Start: 2023-06-14
End: 2023-06-14

Poster #3061: Liquid biopsy identification of ERBB2 amplified and HER2 expressing metastatic breast cancer: Comparison and combination of cell and cell-free platforms

Poster #1053: Validation of a single-cell sequencing assay for the detection of circulating tumor cells in metastatic breast cancer